STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Short Interest Up 35.3% in March

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 2,300 shares, an increase of 35.3% from the February 28th total of 1,700 shares. Based on an average daily volume of 6,000 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.1% of the company’s stock are short sold.

STRATA Skin Sciences Stock Performance

Shares of STRATA Skin Sciences stock traded up $0.03 during trading on Tuesday, hitting $2.67. 201 shares of the company’s stock traded hands, compared to its average volume of 12,090. STRATA Skin Sciences has a 1 year low of $2.51 and a 1 year high of $5.90. The business has a 50-day simple moving average of $2.74 and a 200-day simple moving average of $2.90. The company has a debt-to-equity ratio of 1.62, a current ratio of 1.13 and a quick ratio of 0.94. The stock has a market capitalization of $11.14 million, a P/E ratio of -1.00 and a beta of 1.32.

STRATA Skin Sciences (NASDAQ:SSKN) last announced its quarterly earnings results on Thursday, March 27th. The medical device company reported ($1.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.73). The company had revenue of $33.56 million for the quarter, compared to analysts’ expectations of $9.03 million. STRATA Skin Sciences had a negative net margin of 28.72% and a negative return on equity of 69.33%. As a group, analysts forecast that STRATA Skin Sciences will post -1.05 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Maxim Group assumed coverage on shares of STRATA Skin Sciences in a research note on Thursday, February 27th. They issued a “buy” rating and a $6.00 target price on the stock.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.